3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

R. Gagliardini; A. Bandera; M. Zaccarelli; G. Sterrantino; A. Latini; A. D’Avino; G. Lapadula; A. Antinori; R. Cauda; A. De Luca; A. Gori; S.D. Giambenedetto; M. Fabbiani

doi:10.3851/IMP3188

3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

R. Gagliardini, A. Bandera, M. Zaccarelli, G. Sterrantino, A. Latini, A. D’Avino, G. Lapadula, A. Antinori, R. Cauda, A. De Luca, A. Gori, S.D. Giambenedetto, M. Fabbiani

Istituto S. Maria e S. Gallicano

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	139-148
Number of pages	10
Journal	Antiviral Therapy
Volume	23
Issue number	2
DOIs	https://doi.org/10.3851/IMP3188
Publication status	Published - 2018

Access to Document

10.3851/IMP3188

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047149722&doi=10.3851%2fIMP3188&partnerID=40&md5=79739d9f5f6f17c16a6f6f679e4f1ef4

Cite this

Gagliardini, R., Bandera, A., Zaccarelli, M., Sterrantino, G., Latini, A., D’Avino, A., Lapadula, G., Antinori, A., Cauda, R., De Luca, A., Gori, A., Giambenedetto, S. D., & Fabbiani, M. (2018). 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. Antiviral Therapy, 23(2), 139-148. https://doi.org/10.3851/IMP3188

Gagliardini, R, Bandera, A, Zaccarelli, M, Sterrantino, G, Latini, A, D’Avino, A, Lapadula, G, Antinori, A, Cauda, R, De Luca, A, Gori, A, Giambenedetto, SD & Fabbiani, M 2018, '3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir', Antiviral Therapy, vol. 23, no. 2, pp. 139-148. https://doi.org/10.3851/IMP3188

@article{5e44a131e4914e278035db13df1634a5,

title = "3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir",

author = "R. Gagliardini and A. Bandera and M. Zaccarelli and G. Sterrantino and A. Latini and A. D{\textquoteright}Avino and G. Lapadula and A. Antinori and R. Cauda and {De Luca}, A. and A. Gori and S.D. Giambenedetto and M. Fabbiani",

note = "cited By 0",

year = "2018",

doi = "10.3851/IMP3188",

language = "English",

volume = "23",

pages = "139--148",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "2",

}

TY - JOUR

T1 - 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

AU - Gagliardini, R.

AU - Bandera, A.

AU - Zaccarelli, M.

AU - Sterrantino, G.

AU - Latini, A.

AU - D’Avino, A.

AU - Lapadula, G.

AU - Antinori, A.

AU - Cauda, R.

AU - De Luca, A.

AU - Gori, A.

AU - Giambenedetto, S.D.

AU - Fabbiani, M.

N1 - cited By 0

PY - 2018

Y1 - 2018

U2 - 10.3851/IMP3188

DO - 10.3851/IMP3188

M3 - Article

VL - 23

SP - 139

EP - 148

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 2

ER -